Evidence map›Paper›PMID 42164121›Full record

ArticleFrontiers in oncology2026

Skin tumor identification by means of convolutional neural network and improved gray wolf optimizer.

Mei Ou, Hongmei Wu, Hong Liu, Jing Zhu

Abstract read
In one paragraph

Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Mei OuDepartment of Dermatology, Hamilton Medical Aesthetic Hospital, Chengdu, Sichuan, China.
Hongmei WuDepartment of Dermatology, The Second People's Hospital of Neijiang, Neijiang, Sichuan, China.
Hong LiuDepartment of Dermatology, Zizhong People's Hospital, Neijiang, Sichuan, China.
Jing ZhuDepartment of Radiology, The General Hospital of Western Theater Command, Chengdu, Sichuan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Early and accurate diagnosis of skin cancer has a huge impact on the survival rate of patients and deep learning-based CNN and dermatologists' intelligence support can fasten the diagnosis not only within the clinics but also outside. Methods: This paper introduces a hybrid classification framework for automatic detection of melanoma that combines deep learning and better optimization. A modified GWO method called improved GWO (IGWO) has been proposed which can efficiently optimize CNN parameters and feature learning. Conventional GWO has drawbacks such as early convergence and poor exploration in high-dimensional spaces, so the IGWO regenerates the weak omega agents based on their fitness level. The underperforming omega wolves were discarded in every step and then either the elite solutions (alpha, beta, delta) or the stochastically resampled solution was put to the wolves so that both exploration and exploitation would reach better state. Results: The presented CNN/IGWO model has been experimented with a skin cancer dataset SIIM-ISIC 2020. The proposed model yielded test accuracy of 98.47% and AUC of 98.2 respectively that were both higher than those models using basic GWO method and other state-of-the-art deep learning methods. Discussion: These outcomes show that using the IGWO mechanism along with training of CNN speeds up convergence, enhances the solution and thus the classification performance. The proposed method shows that intelligence-based optimization could give more practical, accurate results in automated melanoma diagnosis.

Indexed as

convolutional neural networkdeep learningimproved gray wolf optimization algorithmskinskin cancer diagnosis

Identifiers

PMID42164121
PMCPMC13183528

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.